On the physiology of airway absorption of allergens

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 57, 1999, Pages 31-36

  Greiff, Lennart ^a   Persson, C G A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALLERGEN; BUDESONIDE; GLUCOCORTICOID; IMMUNOGLOBULIN;

ALLERGY; HUMAN; IMMUNE SYSTEM; MUCOSAL IMMUNITY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT MUCOSA; REVIEW;

ABSORPTION; ALLERGENS; ANIMALS; BRONCHI; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY; NASAL MUCOSA;

EID: 0032721855     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. 1. Mygind N, Pipkom U. Allergic and vasomotor rhinitis. Copenhagen: Munksgaard, 1987:1-223.
2. 2. Erjefält I, Persson CGA. Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucosa. Clin Exp Allergy 1991;21:217-224.
3. 3. Greiff L, Erjefält I, Wollmer P, Pipkom U, Persson CGA. Effects of histamine, ethanol, and a detergent on exudation and absorption across the guinea pig airway mucosa in vivo. Thorax 1991;46:700-705.
4. 51Cr-EDTA across the human nasal mucosa in the presence of topical histamine. Thorax 1991;146:630-632.
5. 5. Persson CGA, Erjefält I, Alkner U, et al. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 1991;21:17-24.
6. 6. Persson CGA, Erjefält I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 1990;92:148-153.
7. 7. Gustafsson B, Persson CGA. Asymmetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. Clin Exp Allergy 1991;21:121-126.
8. 8. Erjefält JS, Greiff L, Sundler F, Persson CGA. Basal cells promptly flatten out at detachment of the columnar epithelium in human and guinea-pig airways. Eur Respir J 1995;8(Suppl. 19):2078.
9. 9. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Microcirculation-derived factors in epithelial repair. Microvasc Res 1994;148:161-178.
10. 10. Erjefält JS, Erjefält I, Sundler F, Persson CGA. In vivo restitution of airway epithelium. Cell Tissue Res 1995;281:305-316.
11. 11. Persson CGA. Permeability changes in obstructive airway disease. In: Sluiter HJ, Van der Lende R, editors. Bronchitis IV. Assen: van Gorcum, 1989;236-246.
12. 12. Salvaggio JE, Cavanaugh JJA, Lowell FC, Leskowitz S. A comparison of the immunologic responses of normal and atopic individuals to intranasally administered antigen. J Allergy 1964;35:62-69.
13. 13. Salvaggio JE, Kayman H, Leskowitz S. Immunologic responses of atopic and normal individuals to aerosolized dextran. J Allergy 1966;38:31-39.
14. 14. Richardson JB, Hogg JC, Bouchard T, Hall L. Localization of antigen in experimental bronchoconstriction in guinea-pigs. J Allergy Clin Immunol 1973;52:172-181.
15. 15. Boucher RC, Ranga V, Parc PD, Inoue S, Moroz LA, Hogg JC. Effect of histamine and methacholine on guinea pig tracheal permeability to HRP. J Appl Physiol 1978;45:939-948.
16. 16. Ranga V, Powers MA, Padilla M, Strope GL, Fowler L. Kleinerman J. Effect of allergic bronchoconstriction on airways epithelial permeability to large polar solutes in the guinea pig. Am Rev Respir Dis 1983;128:1065-1070.
17. 17. Buckle FG, Cohen AB. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol 1975;55:213-221.
18. 18. Cohen MB, Ecker EE, Breitbart JR, Rudolph JA. The rate of absorption of ragweed pollen material from the nose. J Immunol 1930;18:419-425.
19. 19. Kontou-Karakitsos K, Salvaggio JE, Mathews KP. Comparative nasal absorption of allergens in atopic and nonatopic subjects. J Allergy Clin Immunol 1975;55:241-248.
20. 20. Jahnke V. Ultrastructur der allergischen Nasenschleimhaut des Menschen. Z Laryngol Rhinol 1972;51:152-162.
21. 21. Inagaki M, Sakakura Y, Itoh H, Ukai K, Miyoshi Y. Macromolecular permeability of the tight junction of the human nasal mucosa. Rhinology 1985;23:213-221.
22. 22. Laitinen LA, Laitinen A, Persson CGA. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
23. 23. Kondo M, Finkbeiner WE, Widdicombe JH. Changes in permeability of dog tracheal epithelium in response to hydrostatic pressure. Am J Physiol 1992;262:L176-L182.
24. 24. Herbert CA, Edwards D, Boot JR, Robinson C. Stimulated cosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa. Br J Pharmacol 1993;110:840-846.
25. 25. Yamaya M, Sekizawa K, Matsuda T, Morikawa M, Sawai T, Hidetada S. Oxidants affect permeability and repair of the cultured human tracheai epithelium. Am J Physiol 1995;228:L284-L293.
26. 26. Salvaggio JE, Leskowitz S. A comparison of the immunologic responses of normal and atopic individuals to parenterally injected alum precipitated protein antigen. Int Arch Allergy 1965;26:264-279.
27. 27. Richardson JB, Hogg JC, Bouchard T, Hall DL. Localization of antigen in experimental bronchoconstriction in guinea pigs. J Allergy Clin Immunol 1973;52:172-181.
28. 28. Simani AS, Inoue S, Hogg JC. Penetration of the respiratory epithelium of guinea-pigs following exposure to cigarette smoke. Lab Invest 1974;31:75-81.
29. 29. Boucher RC, Johnson J, Inoue S, Hulbert W, Hogg JC. The effect of cigarette smoke on the permeability of guinea-pig airways. Lab Invest 1980;43:94-100.
30. 30. Persson CGA. Role of plasma exudation in asthmatic airways. Lancet 1986;2:1126-1129.
31. 31. Van der Graaf EA, Out TA, Roos CM, Jansen HM. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Am Rev Respir Dis 1991;143:362-368.
32. 32. Walker DC, MacKenzie A, Wiggs BR, Hulbert WC, Hogg JC. The structure of tight junctions in the tracheal epithelium may not correlate with permeabilty. Cell Tissue Res 1984;235:607-613.
33. 33. Hogg JC, Walker DC. Pathology of the airway epithelium in asthma. Clin Respir Physiol 1986;22:12-19.
34. 34. Persson CGA, Svensson C, Greiff L, Andersson M, Wollmer P, Alkner U, Erjefält I. Use of the nose to study the inflammatory response in the respiratory tract. Thorax 1992;47:993-1000.
35. 2. Am Rev Respir Dis 1992;147:A455.
36. 36. Walsh JJ, Dietlein LF, Low FN, Burch GE, Mogabgab WJ. Bronchotracheal response in human influenza. Arch Int. Med 1961;108:376-388.
37. 99mTc-DTPA from guinea pig nasal, tracheo-bronchial and broncho-alveolar airways. Thorax 1990;45:841-845.
38. 52Cr-EDTA in smokers and control subjects. Clin Exp Allergy 1994;24:1036-1040.
39. 39. Andersson M, Greiff L, Öhman H, Svensson C, Wollmer P, Persson CGA. Permeation of polysuccrose 15000 across the human nasal mucosa in vivo. Allergy 1997;52:1229-1232.
40. 40. Andersson M, Greiff L, Svensson C, Persson CGA. Mechanisms of nasal hyperreactivity. Eur Arch Otorhinolaryngol 1995;252:S22-S26.
41. 41. Svensson C, Andersson M, Greiff L, Alkner U, Persson CGA. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995;25:942-950.
42. 42. Greiff L, Svensson C, Andersson M, Persson CGA. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995;50:225-229.
43. 43. Greiff L, Andersson M, Åkerlund A, et al. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold. Thorax 1994;49:121-127.
44. 44. Greiff L, Pipkom U, Alkner U, Persson CGA. The "nasal pool-device" applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990;20:253-259.
45. 51-labelled EDTA. Thorax 1993;48:648-650.
46. 46. Greiff L, Lundin S, Svensson C, Andersson M, Wollmer P, Persson CGA. Reduced airway absorption in seasonal allergic rhinitis. Am J Respir Crit Care Med 1997;156:783-786.
47. 99mTc-DTPA in asthma. Am Rev Respir Dis 1989;139:1139-1143.
48. 113mIn-DTPA in asthma and the effects of salmeterol. Eur Respir J 1993;6(Suppl. 17): 512s.
49. 49. O'Byme PM, Dolovich M, Dirks R, Roberts RS, Newhouse MT. Lung epithelial permeability: relation to non-specific airway responsiveness. J Appl Physiol 1984;57:77 84.
50. 50. Noach ABJ. Enhancement of paracellular drug transport across epithelia. In vitro and in vivo studies (thesis).Leyden University, 1994.
51. 51. Fanner SG, Hay DWP. The airway epithelium. New York: Dekker, 1991:1-677.
52. 52. Robinson C, Kalsheker NA, Srinivasan N, et al. On the potential relevance of the enzymatic activity of mite allergens to immunogenicity. Clues to structure and function revealed by molecular characterisation. Clin Exp Allergy 1997;27:10-21.
53. 53. Herbert CA, Holgate ST, Robinson C, Thompson PJ, Stewart DA. Effect of mite allergen on permeability of bronchial mucosa. Lancet 1990;2:1132.
54. 54. Herbert CA, King CM, Ring PC, et al. Augmentation of permeability in the bronchial epithelium by the house dust mite, allergen Der p 1. Am J Respir Cell Mol Biol 1995;12:369-378.
55. 55. Greiff L, Andersson M, Svensson C, Wollmer P, Lundin S, Persson CGA. Airway absorption of the peptide desmopressin in seasonal and perennial allergic rhinitis. J Allergy Clin Immunol 1996;97:A41.
56. 56. Persson CGA, Erjefält JS, Andersson M, et al. Epithelium, microcirculation and cosinophils - new aspects of the allergic airway in vivo. Allergy 1997;52:241-255.
57. 57. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Effects of topical budesonide on epithelial restitution in vivo in guinea-pig trachea. Thorax 1995;50:785-792.
58. 58. Greiff L, Andersson M, Svensson S, Åkerlund A, Alkner U, Persson CGA. Effects of two weeks' topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. Eur Respir J 1997;10:841-845.
59. 59. Svensson C, Andersson M, Greiff L, Persson CGA. Effects of topical budesonide and levocabastine on nasal responses during a Swedish pollen season. Eur J Allergy Clin Immunol 1998;53:367-374.
60. 60. Minshall E, Ghaffar O, Cameron L, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray [Nasonex] in the treatment of perennial allergic rhinitis. Otolaryngol Head Neck Surg 1998;118:648-654.